Agoracom Blog Home

Archive for the ‘Namaste Technologies Inc.’ Category

How to Invest in Canada’s Coming Legal #Cannabis Boom $N.ca $TBP.ca $MCOA

Posted by AGORACOM-JC at 4:23 PM on Tuesday, February 13th, 2018
  • In just the first six weeks of 2018, 15 of Canada’s 28 public cannabis companies have raised a combined C$1.2 billion selling securities.
  • Many investors have opted instead to focus on Canada, which has a federally legal medical cannabis program and is on the cusp of becoming the first country with federally legal access for all adults

Investing in US-based cannabis companies can be tricky, but Canadian-based companies have few of the same legal risks. (MJ_Prototype/iStock)

For those looking to invest in the legal cannabis industry, companies in the U.S. offer a quandary. Since cannabis remains federally illegal, these companies are all at risk of prosecution, a risk that may have increased earlier this year when Jeff Sessions rescinded the Cole Memo, the departmental guidance that protected states and operators as long as they adhered to the memo’s eight principles.

In just the first six weeks of 2018, 15 of Canada’s 28 public cannabis companies have raised a combined C$1.2 billion selling securities.

Many investors have opted instead to focus on Canada, which has a federally legal medical cannabis program and is on the cusp of becoming the first country with federally legal access for all adults.

What makes the Canadian cannabis sector even more interesting than its ability to service its own population legally is that many of the licensed producers (LPs) are actively involved in international markets like Europe, Australia, Latin America and Israel.

These companies are not only able to export but are also in the process of applying for licenses to operate cultivation facilities in conjunction with local investors. Germany is a particularly exciting medical cannabis market due to insurance reimbursement and distribution through traditional pharmacies.

Your Options: 28 Public Companies

Health Canada, which oversees the licensing and regulation of the Canadian cannabis industry, has approved 89 licenses, some of which have been awarded to companies holding multiple licenses. There are 28 cannabis companies that trade publicly on the Toronto Stock Exchange, the TSX Venture Exchange or the Canadian Securities Exchange. Many of these have U.S. listings as well on the OTC.

So far in just the first six weeks of 2018, 15 of these public companies have raised a combined C$1.17 billion selling securities. This access to capital is a big difference between Canadian and U.S. cannabis companies. I expect that there will be another five or so trading publicly within the next three months.

I’ve created an index for those interested in tracking the performance of this sector: the Canadian Cannabis LP Index. I break it into three different segments, including Tier 1, the largest producers, Tier 2, those that are generating sales but not at the same scale as the leaders, and Tier 3, those companies that have received their license to cultivate but aren’t yet permitted to sell. Overall, the sector has performed very well over the past two years, though it has undergone a sharp correction over the past few weeks.

The top tier includes six companies that are all generating annual sales in excess of C$16 million. These include Aurora Cannabis, Aphria, CanniMed Therapeutics, MedReleaf, CannTrust Holdings and Canopy Growth. CanniMed and Aurora Cannabis are in the process of merging, with an expected closing next month. Note that Aurora Cannabis and Canopy Growth are clients of New Cannabis Ventures, where I serve as managing partner. This article is not intended to be a recommendation of these companies or any others that I mention.

Daily Trading Exceeds C$1 Billion

With the exception of CannTrust, which trades on the Canadian Securities Exchange, each of the others trades on the Toronto Stock Exchange. The combined daily trading value of Aphria, Aurora Cannabis and Canopy Growth has been exceeding C$1 billion regularly, meaning that investors can buy and sell these names without moving the market. The other 22 publicly-traded companies also provide reasonable liquidity for the most part.

At least two exchange-traded funds (ETFs) are heavily invested in Canadian LPs.

U.S. investors interested in buying Canadian licensed producers are best off opening an account that allows them to buy and sell Canadian securities directly, but it is also possible to buy the U.S. listings.

Another alternative is to consider exchange-traded funds (ETFs). I wasn’t a fan of Horizons Marijuana Life Sciences Index ETF when it debuted in April, but it has improved. At this point, Canadian LPs make up more than 80% of the Horizon ETF’s holdings. The fund manager is launching a second ETF this week, the Emerging Marijuana Growers Index ETF, which includes smaller companies, over half of which are Canadian LPs.

High Valuations, Higher Expectations

Despite the recent decline in prices, the valuations of Canadian LPs are high relative to their current rate of sales. Still, with legalization kicking in later this year, future sales are expected to rise substantially. Canopy Growth and Aurora Cannabis have market capitalizations of about C$6 billion, followed by Aphria at C$2.8 billion, MedReleaf at C$1.9 billion, CanniMed at C$882 million and CannTrust at C$793 million. The U.S market caps are about 20% lower based on the current Canadian dollar exchange rate of $0.795.

Bottom line: Canadian cannabis companies are perhaps safer investments than those in the U.S. due to being federally legal, but they have performed very well and may be overvalued despite a recent sell-off. Investors looking to capitalize on global cannabis opportunities should consider exploring this group of companies, which currently numbers 28 and is likely to expand in the near term.

Next up: I discuss the hazards of investing in the stocks of publicly-traded producers of CBD from industrial hemp.

As an owner of New Cannabis Ventures, Alan Brochstein works with several publicly-traded and privately held cannabis companies as he discloses here. In the event he mentions a company that is a client, he will disclose it in the article as well.Source: https://www.leafly.com/news/industry/how-to-invest-in-canadas-coming-legal-cannabis-boom

The week in #marijuana deals: Emerald online, #ABcann gets clinical and #Wheaton goes to Uruguay $N.ca $ACB.ca $HIP.ca $WEED.ca $CMED.ca $TBP.ca

Posted by AGORACOM-JC at 10:31 AM on Monday, February 5th, 2018

  • Namaste Technologies Inc. and B.C.-based LP Emerald Health Therapeutics Inc., announced on Tuesday that they were joining forces to develop a new e-commerce platform for Emerald products.
  • Emerald will use Namaste’s online technology to sell its cannabis alongside Namaste’s catalogue of “cannabis delivery devices.

Aphria Inc.’s announcement on Monday morning that it was buying little-known Nuuvera Inc. for an implied value of $826 million kicked the week off with a bang. By Friday, however, optimism in the sector had hit a wall. The Canadian Marijuana Index shed more than 30 per cent between Monday and Friday, and the week ended with a volatile day of sell-offs and opportunistic buys. While the cannabis stock market shuddered, companies continued to make deals. Here are a few you may have missed.

Emerald Goes Online

Namaste Technologies Inc., an online retailer of cannabis related products, and B.C.-based LP Emerald Health Therapeutics Inc., announced on Tuesday that they were joining forces to develop a new e-commerce platform for Emerald products. Emerald will use Namaste’s online technology to sell its cannabis alongside Namaste’s catalogue of “cannabis delivery devices.” Emerald will also provide product to Namaste’s subsidiary Cannmart Inc., which is currently applying for a sales-only licence under the ACMPR. Under the deal, the companies will each get 500,000 warrants for the other’s stocks.

Getting Clinical

On Thursday, licensed producer ABcann Global Corp. completed its acquisition of Harvest Medicine Inc., a medical cannabis clinic in Calgary with 9,700 patients, according to the company. ABcann plans to develop additional Harvest Medicine clinics, starting with one in Edmonton that’s expected to open this spring. It paid $1.5 million in cash and issued 1,056,338 shares to Harvest Medicine owners, with more promised if the company hits “certain performance milestones.”

Other deals

Winnipeg-based LP Delta 9 Cannabis Inc., which produces cannabis inside “grow pods” made of repurposed shipping containers, plans to develop a production facility in Southern Alberta with private company Westleaf Cannabis Inc. On Monday the companies announced they had signed a non-binding letter of intent to repurpose an existing building into an operation intended to produce 4,000 kilograms of dried flower a year. Each company will take a 50 per cent stake in the project, which, according to Delta 9, is expected to be up and running as early as Q3 2018.

Cannabis Wheaton Income Corp. entered into an agreement to buy Uruguay-based Inverell S.A. The federally licensed “cannabis operator,” based in Uruguay’s capital Montevideo, has 16 hectares planted and another 574 hectares available for cultivation, according to a press release from Wheaton Income. Wheaton Income is paying around $5.5 million in cash and shares, and another $9.5 million if Inverell hits certain goals.

iAnthus Capital Holdings Inc., which is based in the U.S. but trades on the Canadian Securities Exchange, acquired New York-based Citiva Medical for US$18 million in cash and shares. Citiva holds one of only 10 medical marijuana licences in New York, and plans to open four dispensaries over the next two years. According to Canaccord Genuity Corp. analyst Matt Bottomley, New York’s medical cannabis market could be worth up to $1 billion annually. There are still concerns, however, about how Canadian regulators will deal with Canadian-listed companies operating in the U.S. where the federal government recently announced its intent to enforce cannabis laws more strictly.

Source: http://business.financialpost.com/investing/the-week-in-marijuana-deals-emerald-online-abcann-gets-clinical-and-wheaton-goes-to-uruguay

Namaste $N.ca Announces Increase in Bought Deal Offering to $35 Million $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 12:05 PM on Thursday, February 1st, 2018

Nlogo

  • Now agreed to purchase 13,726,000 units of the Company on a “bought deal” basis
  • At a price per Unit of $2.55 for gross proceeds of $35,001,300

VANCOUVER, BRITISH COLUMBIA–(Feb. 1, 2018) – NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Namaste Technologies Inc. (CSE:N)(CSE:N.CN)(CNSX:N)(FRANKFURT:M5BQ)(OTCQB:NXTTF) (“Namaste” or the “Company“), is pleased to announce that it has entered into an amended letter of engagement with Eight Capital and Canaccord Genuity Corp. as co-lead underwriters and joint bookrunners, and including Beacon Securities Limited (together, the “Underwriters”), under which the Underwriters have now agreed to purchase 13,726,000 units of the Company (the “Units“), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $2.55 (the “Issue Price“) for gross proceeds of $35,001,300 (the “Offering“).

The Company has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional approximately $5,250,195 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $40,251,495.

Each Unit will be comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $3.15, for a period of 24 months following the closing of the Offering. If, following the closing of the Offering, the volume weighted average price of the Common Shares on the Canadian Securities Exchange is equal to or greater than $6.00 for any 10 consecutive trading days, the Company may, upon providing written notice to the holders of Warrants, accelerate the expiry date of the Warrants to the date that is 30 days following the date of such written notice.

The Company intends to use the net proceeds of the Offering to fund inventory and for working capital and general corporate purposes.

The closing date of the Offering is scheduled to be on or about February 27, 2018 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Canadian Securities Exchange and the applicable securities regulatory authorities.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.co.uk

www.everyonedoesit.co.uk

Forward-Looking Information

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
+1 (786) 389 9771
info@namastetechnologies.com

Namaste $N.ca Enters Into $30 Million Bought Deal Equity Financing $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 8:39 AM on Thursday, February 1st, 2018

Nlogo

  • Entered into a letter of engagement with Eight Capital,  along with a syndicate of underwriters
  • 11,765,000 units of the Company , on a “bought deal” basis pursuant to a filing of a short form prospectus, at a price per Unit of $2.55 for gross proceeds of $30,000,750

VANCOUVER, BRITISH COLUMBIA–(Feb. 1, 2018) – Namaste Technologies Inc. (CSE:N)(CSE:N.CN)(CNSX:N)(FRANKFURT:M5BQ)(OTCQB:NXTTF) (“Namaste” or the “Company“), is pleased to announce that it has entered into a letter of engagement with Eight Capital, under which Eight Capital has agreed to purchase, as sole bookrunner and lead underwriter, along with a syndicate of underwriters (the “Underwriters“), 11,765,000 units of the Company (the “Units“), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $2.55 (the “Issue Price“) for gross proceeds of $30,000,750 (the “Offering“).

The Company has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional approximately $4,500,000 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be approximately $34,500,750.

Each Unit will be comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $3.15, for a period of 24 months following the closing of the Offering. If, following the closing of the Offering, the volume weighted average price of the Common Shares on the Canadian Securities Exchange is equal to or greater than $6.00 for any 10 consecutive trading days, the Company may, upon providing written notice to the holders of Warrants, accelerate the expiry date of the Warrants to the date that is 30 days following the date of such written notice.

The Company intends to use the net proceeds of the Offering to fund inventory and for working capital and general corporate purposes.

The closing date of the Offering is scheduled to be on or about February 27, 2018 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Canadian Securities Exchange and the applicable securities regulatory authorities.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

Sean Dollinger, Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.co.uk

www.everyonedoesit.co.uk

Forward-Looking Information

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
+1 (786) 389 9771
info@namastetechnologies.com

Namaste $N.ca Announces Record-Breaking Quarterly Sales of $4.9M Representing a 133% Year-On-Year Increase $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 6:58 PM on Monday, January 29th, 2018

Nlogo

  • Company’s sales for the three months ending on November 30, 2017, were $4.9M,
  • $2.8M or 136% increase in comparison with the Company’s quarter ended November 30, 2016.

VANCOUVER, British Columbia, Jan. 29, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N), (FRANKFURT:M5BQ), (OTCMKTS:NXTTF) is pleased to announce the filing of its unaudited quarterly financial statements, management’s discussion and analysis and certification of the quarterly filings for the first quarter of fiscal 2017. The statements for the period can be accessed on SEDAR at www.sedar.com. The Company’s sales for the three months ending on November 30, 2017, were $4.9M, representing a $2.8M or 136% increase in comparison with the Company’s quarter ended November 30, 2016.   Gross margin also increased to 32% for the three months ended on November 30, 2017 in comparison to 28% for the Company’s quarter ended November 30, 2016.

During the financial reporting period of September 1, 2017 to November 30, 2017, the Company focused on expanding sales in existing territories as well as in emerging markets such as Mexico and Brazil while reducing sales exposure in the United States.

The Company also sold its US assets and operations as a strategic decision to eliminate risk related to US market exposure.

The Company remains focused on achieving profitability and on launching its medical cannabis marketplace, NamasteMD, through our wholly-owned subsidiary, Cannmart Inc.

Quarterly Financial Highlights

  • The majority of revenues were generated by several key markets. The top five countries generated 84% of revenues for the three months ended November 30, 2017. In the previous year the top five countries generated 79% of revenues. The table below depicts gross revenues by country.

  • The Company’s cost of sales for the three months ended November 30, 2017 were $3.4 million (2016 – $1.5 million), which resulted in a gross profit of $1.6 million (2016 – $0.6 million). The gross profit increased by $1.0 million or 167%, which is primarily due to the growth in revenue outside the United States. The gross profit margin increased year over year from 28% to 32% due to better operating efficiencies.
  • Operating costs were $4.7 million (2016 – $1.5 million), which is an increase of $3.2 million. The increase in operating costs is primarily due to non-cash charges of $2.6 million, which included share-based compensation, shares for services, amortization of intangible assets, and depreciation.
  • Selling expenses for the three months ended November 30, 2017 were $1.1 million (2016 – $0.5 million), which is an increase of $0.6 million. The increase is due in part to an increase in advertising expenses of $0.1 million and consulting expenses of $0.2 million. Advertising expenses relate to online search services as well as other online promotional and social media tools utilized by the Company to generate sales. These costs further represent the Company’s significant investment into search engine optimization and its ongoing customer acquisition strategy. In addition to this, there were non-cash expenses related to shares for services of $0.2 million.
  • Consulting expenses relate to compensation amounts paid to various companies and individuals for marketing, order fulfillment, customer service activities, e-commerce product development, back-office e-commerce support and sales commissions. The increase in consulting fees is primarily related to information technology in order to develop current and new revenue channels that the Company is working towards.
  • Administration expenses for the three months ended November 30, 2017 were $3.3 million (2016 – $0.9 million), which is an increase of $2.4 million. The increase is primarily due to share-based compensation of $2.1 million and shares for services of $0.1 million
  • Other expenses for the three months ended November 30, 2017 were $0.3 million (2016 – approximately nil), which is an increase of $0.3 million. The increase is primarily due to amortization of intangibles of $0.2 million, which relates to the amortization of the customers list from the acquisition of Australian Vaporizers.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “During the first quarter ended November 30, 2017, Namaste embarked on implementing many strategic business initiatives focused on expansion in international markets other than the United States. In addition, posting record-breaking revenues, management remains focused on seeking and securing strong partnerships to further accelerate growth going forward. We expect to see significant upside to Namaste’s revenue and profitability as a direct result of the many acquisitions and partnerships that were initiated both during and following this quarter. Management believes there are many more strategic opportunities that exist in the cannabis market that will serve to strengthen Namaste’s position moving forward. In particular the NamasteMD platform will be key driver of growth.  We are extremely excited at where the industry is headed and believe Namaste is well-positioned in 2018 and beyond.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com

Further information on Namaste and its products can be accessed through the links below:

www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk
www.australianvaporizers.com.au

Namaste $N.ca $NXTTF Announces Supply Agreement With Supreme $FIRE.ca to Purchase 1000 kg of Premium Medical Cannabis $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 8:15 AM on Thursday, January 25th, 2018

Nlogo

  • Announced that its wholly-owned subsidiary, Cannmart, has committed to purchase 1000 kilograms of premium quality medial cannabis from 7ACRES in 2018
  • Agreement represents a significant milestone for Namaste, as its first commitment to a volume purchase of medical cannabis

VANCOUVER, British Columbia, Jan. 25, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(FRA:M5BQ)(OTCMKTS:NXTTF) is pleased to announce that its wholly-owned subsidiary, Cannmart, Inc. (“Cannmart”) and 8528934 Canada Ltd. (“7ACRES”), a wholly-owned subsidiary of The Supreme Cannabis Company, Inc. (“Supreme”) (TSXV:FIRE), have signed a Definitive Supply Agreement (the “Agreement”) whereby Namaste, through its wholly-owned subsidiary, Cannmart, has committed to purchase 1000 kilograms of premium quality medial cannabis from 7ACRES in 2018, commencing on the date that Cannmart becomes a “Licensed Producer” under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”). This Agreement represents a significant milestone for Namaste, as its first commitment to a volume purchase of medical cannabis. Namaste believes that Supreme’s business plan of scaled production of branded, premium cannabis flower aligns itself well with Namaste’s goal of positioning Cannmart as Canada’s largest online retail e-commerce platform for medical cannabis.

Select Terms of the AGREEMENT

Cannmart has agreed to purchase a minimum of 1000 kilograms of medical cannabis in the 2018 calendar year, starting from the date whereby Cannmart becomes a “Licensed Producer” as defined in the ACMPR.
7ACRES has agreed to supply Cannmart with premium medical cannabis at a price of $6,000 per kilogram.
Should Cannmart fail to purchase a minimum of 1000 kilograms of medical cannabis within the 2018 calendar year, Cannmart will be deemed to have purchased, and will pay for, the full 1000 kilograms at the price of $6,000 per kilogram; provided that if 7ACRES cannot supply to Cannmart the amount requested in any given month, then the amount owing shall be reduced by the amount they failed to supply in such month.
Cannmart has agreed to display 7ACRES’ trade-mark on all packaging of the 7ACRES product.

Supreme is focused on producing high quality cannabis through a commitment to carefully curated genetics, quality focused cultivation practices and a post-harvest process that includes a 14-day whole plant drying process and hand finishing of each flower. Namaste anticipates Supreme becoming a key partner in ensuring a strong supply chain for premium medical cannabis flower and looks forward to a long-term, mutually beneficial relationship. Namaste believes this Agreement significantly strengthens its position, and further validates the role the Cannmart facility will soon play in the Canadian cannabis market once the “sales-only” license is received.

Management Commentary
John Fowler, CEO of Supreme comments: “As a cultivation focused Licensed Producer we rely on strong retail partners to provide us access to consumers and favourable brand positioning. We are impressed by the platform being built by Namaste to date, and their innovative strategy to position Cannmart as a “sales-only” entity is a natural fit with our 7ACRES business model. The team at Namaste and Cannmart understand the value of premium cannabis flower and we look forward to taking part in the launch of Cannmart as one of Canada’s first “sales only” Licensed Producers.”

Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to announce this Agreement with Supreme and to make a purchase commitment, which we feel brings significant value in securing supply for premium quality medical cannabis for Cannmart. Namaste feels confident that Supreme’s business strategy as a wholesale producer will lend itself well as Namaste focuses its efforts on the retail component in the medical cannabis industry. We look forward to working with Supreme and their management team and anticipate a long-term relationship that will be beneficial for both companies over the next several years.”

About Supreme
Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Greenhouse facility. The Hybrid Greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit www.supreme.ca and www.7acres.com for more information.

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information
Certain statements made in this press release may constitute forward-looking information under applicable securities laws. These statements are based on Namaste’s current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although Namaste believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because no assurance can be given that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in Namaste’s disclosure documents which can be found under Namaste’s profile on sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com

Further information on Namaste and its products can be accessed through the links below:

Agreement.namastetechnologies.com
Agreement.namastevaporizers.co.uk
Agreement.everyonedoesit.co.uk
Agreement.australianvaporizers.com.au

Aurora $ACB.ca finally wins CanniMed $CMED.ca in Canada’s biggest marijuana deal yet $TBP.ca $N.ca $MCOA

Posted by AGORACOM-JC at 12:10 PM on Wednesday, January 24th, 2018

  • Aurora Cannabis Inc. has struck a friendly deal valued at $1.1 billion to buy rival licensed producer CanniMed Therapeutics Inc
  • The deal, which will be Canada’s largest in the marijuana sector, also means CanniMed will abandon its plans to acquire Newstrike Resources Ltd., whose shareholders had already voted in favour of a takeover by CanniMed

EDMONTON — Aurora Cannabis Inc. has struck a friendly deal valued at $1.1 billion to buy rival licensed producer CanniMed Therapeutics Inc., bringing an end to a lengthy hostile takeover battle between the marijuana companies.

The deal, which will be Canada’s largest in the marijuana sector, also means CanniMed will abandon its plans to acquire Newstrike Resources Ltd., whose shareholders had already voted in favour of a takeover by CanniMed.

CanniMed will pay a $9.5-million break fee to Newstrike as a result of its decision.

Shares in CanniMed were up 16 per cent by midmorning after shooting up 22 per cent directly after the news. Aurora was up half a per cent. Newstrike trading was halted but the stock fell 20 per cent when trading resumed.

“We are very pleased to have come to terms with CanniMed on this powerful strategic combination that will establish a best-in-class cannabis company with operations across Canada and around the world,” Aurora chief executive Terry Booth said.

“Market recognition of Aurora’s continued performance and strategy execution since we first announced our intention to acquire CanniMed allows us to share that benefit directly with CanniMed shareholders by increasing the offer price, as well as by offering a cash component.”

CanniMed had argued that Aurora’s earlier all-stock offer valued at up to $24 per share for the company was too low, given the wild swings in marijuana stocks.

The two appeared to have reached a truce last week, agreeing to talks after a very public and litigious war of words.

Aurora’s new offer includes a cash component. Under the agreement announced Wednesday, CanniMed shareholders will receive 3.4 Aurora shares or a combination of cash and shares for each CanniMed share they hold.

Based on an implied Aurora share price of $12.65 and the 3.40 exchange ratio, the companies said the new offer would equate to $43 per share.

However, Aurora shares closed at $14.79 on the Toronto Stock Exchange on Tuesday making the offer worth about $50.29. CanniMed shares closed at $37.51.

The total amount of cash available under the deal is capped at $140 million. Assuming maximum cash elections, each CanniMed shareholder would receive $5.70 in cash and 2.9493 Aurora shares.

CanniMed chief executive Brent Zettl said the deal was a testament to the team at CanniMed.

“This transaction clearly confirms that the company has been highly successful in becoming a preeminent global leader in the medical cannabis industry,” Zettl said.

The new offer and the transaction are subject to customary closing conditions, including Competition Act approval.

Source: http://business.financialpost.com/commodities/agriculture/newsalert-aurora-cannabis-to-buy-cannimed-therapeutics-in-deal-valued-at-1-1b

Namaste $N.ca $NXTTF Receives Health Canada Confirmation of Readiness $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:38 AM on Monday, January 22nd, 2018

Primary Logo

  • Health Canada’s Office of Medical Cannabis has provided the Company with a Confirmation of Readiness for a license under Canada’s Access to Cannabis for Medical Purposes Regulations
  • For  license under Canada’s Access to Cannabis for Medical Purposes Regulations for the Company’s wholly owned subsidiary, Cannmart Inc.

VANCOUVER, British Columbia, Jan. 22, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that Health Canada’s Office of Medical Cannabis has provided the Company with a Confirmation of Readiness (“COR”) for a license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the Company’s wholly owned subsidiary, Cannmart Inc. (“Cannmart”). Cannmart is a late-stage applicant under the ACMPR for a medical cannabis “sales-only” license. Namaste plans to leverage its growing site traffic and existing consumer databases along with the Company’s revolutionary patient acquisition tool, NamasteMD.com, to become Canada’s leading e-commerce retailer for medical cannabis products.

Further to receiving the COR and as construction of the Cannmart facility nears completion, the Company is now focused on providing all additional information as required by Health Canada in order to have the “sales-only” license issued.

Once Cannmart’s ACMPR “sales-only” license is issued, the Company will focus on sourcing medical cannabis from a large variety of domestic and international producers in order to offer the largest variety of strains to its patients. Namaste’s goal is to create a simplified user experience to assist patients with a smooth onboarding process and access to the highest quality products available on the market.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “We are beyond excited to receive this amazing news. After all of the hard work and dedication from our management team as well as our consultants, we believe we are finally poised to execute on our strategy to become the most comprehensive online marketplace for medical cannabis in Canada. Once the sales license is issued, we will focus on sourcing high-quality products from local ACMPR licensed producers with a specific focus on craft cannabis brands as we bring great value and exposure for all producers, big and small.

This is a monumental day for the Company and I’m very proud of our team and I would also like to take this opportunity to thank all of our peers in the cannabis industry who saw value in both the products and services we are able to provide and decided to work collaboratively with Namaste for the betterment of all Canadian cannabis patients. While this is an important step in our journey, we believe this is only the beginning of a transformational year for Namaste and its shareholders.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com

Further information on Namaste and its products can be accessed through the links below:

Agreement.namastetechnologies.com
Agreement.namastevaporizers.co.uk
Agreement.everyonedoesit.co.uk
Agreement.australianvaporizers.com.au

 

BMO $BMO.ca marks first foray by a major Canadian bank in #marijuana sector with $175M deal $TBP.ca $N.ca $MCOA $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 2:42 PM on Thursday, January 18th, 2018

  • Bank of Montreal broke new ground Wednesday for the “Big Five” Canadian lenders with its participation in a major marijuana deal
  • Canopy Growth Corp., Canada’s largest licensed producer of medical cannabis, announced an approximately $175-million bought-deal offering Wednesday

Smiths Falls, Ont.-based Canopy Growth Corp., Canada’s largest licensed producer of medical cannabis, announced an approximately $175-million bought-deal offering Wednesday of a little more than five million shares of the company.

Canopy noted in a release that GMP Securities LP and Bank of Montreal-owned BMO Capital Markets were leading the transaction for the company as joint bookrunners, marking the first time a major Canadian bank has helped head an equity financing for a publicly traded company in the medical marijuana industry.

“This is the first time a major Canadian bank-owned brokerage has participated in a cannabis securities issue,” wrote Chris Damas, editor of the BCMI Cannabis Report.

A spokesperson for Canopy confirmed that the transaction marked the first such foray by a Big Five Canadian bank.

“Although this does not guarantee participation in the cannabis sector by all six of the largest Canadian Schedule 1 banks (BMO had already been a banker for cannabis companies), it is very positive for the sector, all things being equal,” Damas added.

Other major Canadian banks have yet to dive into the country’s growing cannabis sector in the same way BMO has, and are likely hesitant to do so given their significant business in the United States, where marijuana is still illegal under federal law. But some banks, including BMO, have provided business accounts for cannabis companies, according to Bloomberg.

That stance may now be starting to soften amid a fundraising spree in the Canadian marijuana industry, which had been taking place without the country’s biggest banks. Companies involved in the already legal medical pot business have been seeking funding to serve the coming recreational market set to be legalized by the federal government this summer.

Royal Bank of Canada told the Financial Post in a statement last week that it “currently does not provide banking services to companies engaged in the production and distribution of marijuana.”

“We recognize that the legislative landscape is evolving and we are undergoing a review of our policies,” added the lender.

A spokesperson for Bank of Nova Scotia told the Post on Friday that “we must balance that with our commitment to effectively manage all business risks.”

“While we understand there is a robust debate in Canada and abroad, our priority is to manage risk for our customers and stakeholders to ensure they are protected,” said Scotiabank’s Rick Roth in an email. “Should there be significant change to industry legislation or regulation, we will revisit our risk assessment and make risk policy adjustments if warranted.”

Toronto-Dominion Bank and the Canadian Imperial Bank of Commerce either declined to comment or had yet to respond as of Thursday morning.

Canopy said its agreement with the underwriters includes an over-allotment option for them, allowing for the purchase of up to 759,000 additional shares at the offering price of $34.60 per share, worth nearly $26.3 million. The company said that the deal is expected to close on Feb. 7, subject to some conditions, and that the net proceeds will be used “for capital expenditures for capacity expansion, working capital, and general corporate requirements.”

Source: http://business.financialpost.com/investing/bank-of-montreal-marks-first-for-major-canadian-lenders-with-175m-marijuana-deal

Namaste $N.ca Announces 5% Equity Purchase LOI with Cannbit Ltd. $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:09 AM on Thursday, January 18th, 2018

Nlogo

  • Company has signed a non-binding Letter of Intent with Israeli medical cannabis producer, Cannbit Ltd
  • Namaste would acquire an equity position of 5% in Cannbit through an investment to be made in a proportion to be determined and agreed by both parties

VANCOUVER, British Columbia, Jan. 18, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N), (FRANKFURT:M5BQ), (OTCMKTS:NXTTF) is pleased to announce that the Company has signed a non-binding Letter of Intent (“LOI”) with Israeli medical cannabis producer, Cannbit Ltd (“Cannbit)” whereby the companies propose to enter into a share purchase agreement and/or a subscription agreement (the “Agreement”) whereby Namaste would acquire an equity position of 5% in Cannbit through an investment to be made in a proportion to be determined and agreed by both parties. Cannbit will also offer Namaste a first right of refusal to purchase an additional 5% equity in shares at the same valuation.

Further to the Company’s September 15th, 2017 announcement of signing a Wholesale Supply Agreement (“Supply Agreement”) with Cannbit, Namaste intends to purchase high-quality medical grade cannabis from Cannbit through the Company’s wholly owned subsidiary, Cannmart Inc. (“Cannmart”). The Company is pleased to have the opportunity to participate in an equity position with Cannbit and in developing a long-term relationship that will be mutually beneficial to both parties. Cannmart is a late stage applicant for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) medical cannabis “sale-only” license. Through Cannmart, Namaste plans to offer the largest variety of medical cannabis products to its patients through the sourcing of both domestic and internationally imported products. Namaste hopes to leverage its vast expertise with e-commerce, conversion rate optimization and enterprise technology to create Canada’s leading online marketplace for medical cannabis.

Terms of the LOI:

  • Namaste will make an investment in Cannbit in exchange for 5% equity, whereby the amount will be determined by a valuation agreed to by both parties.
  • Namaste will have a first right of refusal to purchase an additional 5% equity position in Cannbit, at the same valuation as originally agreed upon, for a period of one year from the date of execution of the proposed agreement.
  • Closing of the proposed agreement will be contingent upon negotiating and execution of definitive documentation and approval of the terms of the agreement by each party’s respective board of directors and shareholders, if applicable, and by the Canadian Securities Exchange, if applicable.

Namaste’s strategic investment in Cannbit, as well as other domestic and international licensed producers of medical cannabis, will bring value to the company in securing strong partnerships with leading cannabis cultivators to ensure ample supply of the largest variety of high-quality medical cannabis in the Canadian market. Namaste plans to seek additional opportunities by implementing Cannmart’s business model in other regions where the Company maintains significant market share.

Sean Dollinger, President and CEO of Namaste comments: “We’re very much looking forward to working with Cannbit and their team to import exceptionally high-quality medical cannabis into the Canadian market. Namaste expects to see strong value in this investment, as well as through the supply arrangement with Cannbit. We will continue to seek relationships with leading cultivators domestically and abroad. We are highly focused on creating a superior user experience and better availability of products for our patients, and believe this transaction will help us achieve that goal. Thank you to Cannbit’s management team for working hard to secure this LOI and Supply Agreement. We look forward to many years of business together and are excited at the opportunity to give Canadians access to the Israeli cannabis market.”

Yaron Razon, President and CEO of Cannbit Comments “We are very excited to have this partnership and strategic cooperation with Namaste. We believe Namaste is well-positioned with an impressive global marketing and distribution platform and led by a brilliant management team. Together with Namaste, Cannbit will reach many patients across the world with premium medical grade cannabis to help treat their health conditions. We anticipate exploring new opportunities with Namaste and are looking forward to working together soon.”

About Cannbit Ltd.

Cannbit is focused on growing high-quality medical-grade cannabis with advanced technology and agriculture platform while utilizing the best human resources to produce the highest level of quality available that will effectively treat a wide range of illnesses. The Israeli government is expected to approve the export of medical cannabis and Cannbit intends to become Israel’s leading exporter for medical cannabis to legal jurisdictions around the globe. Cannbit’s facility is 4,000 square meters with an additional 10,000 square meters available for expansion and is located in Neot Hakikar, an area well known in the Israeli agricultural community with clear advantages in the cold seasons. Our cultivation is carried out in a sophisticated greenhouse that provides ideal conditions for a variety of cannabis strains. Cannbit’s management is comprised of a group of industry professionals in relevant disciplines.

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: info@namastetechnologies.com

Further information on Namaste and its products can be accessed through the links below:

www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk
www.australianvaporizers.com.au